Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 17:22:e00177.
doi: 10.1016/j.plabm.2020.e00177. eCollection 2020 Nov.

Effect of anticoagulant adjustment on prothrombin time test using two different PT reagents in patients with elevated hematocrit

Vanessa M Silva  1 , Denise C Rezende  1 , Edna S Garcia  1 , Cyrillo Cavalheiro  2 , Celia C Strunz  1
Affiliations

Effect of anticoagulant adjustment on prothrombin time test using two different PT reagents in patients with elevated hematocrit

Vanessa M Silva et al. Pract Lab Med. .

Abstract

The recommendations for adjustment of citrate volume in sample tubes with high hematocrit (Ht) are based on indirect studies of underfilled tubes or artificially constructed Ht values. The aim of this study was to evaluate the effect of citrate volume adjustment in sample tubes from patients with hematocrit >55% using two different prothrombin time (PT) tests.

Methods: Paired citrate-adjusted and unadjusted blood specimens were obtained from 181 patients from the pulmonary hypertension ambulatory with high Ht values and on warfarin therapy. The samples were tested using recombinant human tissue factor (RTF) and reagents extracted from rabbit brain (HS Plus). The results are expressed as the international normalized ratio (INR). The correlation and percent change (% change) between sample pairs were calculated.

Results: INR-RTF results from adjusted and unadjusted citrate blood specimens showed a strong correlation (R2 ​= ​0.8226, p ​< ​0.0001). The INR median was 2.25 (95% CI 2.10 to 2.41) for citrate-adjusted samples and was 2.22 (95% CI 2.06 to 2.38) for citrate-unadjusted samples. For samples with Ht >62%, the % change between sample pairs was >10%. Results using HS Plus showed a moderate correlation between citrate-adjusted and unadjusted samples (R2 ​= ​0.4267, p ​< ​0.0001). The INR median was 2.51 (95% CI 2.35 to 2.68) for citrate-adjusted samples and 3.45 (95% CI 3.11 to 3.80) for citrate-unadjusted samples. For samples with Ht>55%, the % change between sample pairs was higher than 10%.

Conclusion: Our data demonstrate that in patients with polycythemia on warfarin therapy, INR-RTF does not require anticoagulant adjustment for assessment of samples with Ht <62%.

Keywords: Citrate adjustment; Hematocrit; Prothrombin time; Thromboplastins.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Fig. 1
Fig. 1
Percentage difference between RTF-PT and HS Plus PT. The percentage difference is the change between the citrate-adjusted and unadjusted samples. See the “Materials and Methods” section for details.
See this image and copyright information in PMC

References

    1. Favaloro E.J., Lippi G., Adcock D.M. Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis? Semin. Thromb. Hemost. 2008;34(7):612–634. doi: 10.1055/s-0028-1104540. - DOI - PubMed
    1. Pai S.H., Michalaros K. Effect of sample volume on coagulation tests. Lab. Med. 1990;21(6):371–373. doi: 10.1093/labmed/21.6.371. - DOI
    1. Marlar R.A., Potts R.M., Marlar A.A. Effect on routine and special coagulation testing values of citrate anticoagulant adjustment in patients with high hematocrit values. Am. J. Clin. Pathol. 2006;126(3):400–405. doi: 10.1309/RRQKT2JEYV33D19D. - DOI - PubMed
    1. Who Expert Committee on Biological Standardization . World Health Organization Technical Report Series; 1999. Guidelines for thromboplastins and plasma used to monitor oral anticoagulant therapy; p. 889. - PubMed
    1. Fairweather R.B., Ansell J., van den Besselaar A.M., Brandt J.T., Bussey H.I., Poller L., Triplett D.A., White R.H. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy. Arch. Pathol. Lab Med. 1998;122(9):768–781. - PubMed

LinkOut - more resources